Professor Lucyna Wozniak, Vice-Rector for Research and International Relations-Medical University in Lodz (MUL). Chair of Medicinal Biology, Head of Department of Structural Biology
PhD and habilitation: Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences Lodz. Post-doctoral fellowship Kings College London (Prof. Colin B. Reese), synthesis of biomolecules, derivatives of nucleic acids (DNA & RNA).
Worked in the Polish Academy of Sciences, Lodz. on the synthesis of nonionic analogues of DNA/RNA, analysis of interactions of oligonucleotide (3’,5’)-methanephosphonates with other molecules. Research collaboration with Genta, Lexington, U.S.A, on antisense molecules as antivirus and anticancer drugs.
Dept. of Structural Biology working on molecular mechanisms and early predictors/biomarkers of metabolic diseases (diabetes, in particular, Gestational Diabetes), and cancer (applying metabolomics, transcriptomics and lipidomics).
Activities: Member of Supervisory Board EIT HEALTH. Chairperson of EIT Health InnoStars Supervisory Board. Member of the High-Level Group on maximising impact of EU Research and Innovation Programmes. Chairperson of the Advisory Board to Łukasiewicz Research Network.
Professor Lucyna Wozniak, Vice-Rector for Research and International Relations-Medical University in Lodz (MUL). Chair of Medicinal Biology, Head of Department of Structural Biology
PhD and habilitation: Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences Lodz. Post-doctoral fellowship Kings College London (Prof. Colin B. Reese), synthesis of biomolecules, derivatives of nucleic acids (DNA & RNA).
Worked in the Polish Academy of Sciences, Lodz. on the synthesis of nonionic analogues of DNA/RNA, analysis of interactions of oligonucleotide (3’,5’)-methanephosphonates with other molecules. Research collaboration with Genta, Lexington, U.S.A, on antisense molecules as antivirus and anticancer drugs.
Dept. of Structural Biology working on molecular mechanisms and early predictors/biomarkers of metabolic diseases (diabetes, in particular, Gestational Diabetes), and cancer (applying metabolomics, transcriptomics and lipidomics).
Activities: Member of Supervisory Board EIT HEALTH. Chairperson of EIT Health InnoStars Supervisory Board. Member of the High-Level Group on maximising impact of EU Research and Innovation Programmes. Chairperson of the Advisory Board to Łukasiewicz Research Network.